A patient in New York has been infected with a strain of E. coli highly resistant to last-resort antibiotic treatments, according to an article on the Becker's Infection Control and Clinical Quality website.
This is the second U.S. patient with the untreatable superbug infection, following a Pennsylvania patient first made public last month.
The mcr-1 gene gives bacteria resistance to colistin, a last-line-of-defense antibiotic used to combat a number of resistant microorganisms.
Going into 2017, the White House has requested $1.1 billion be allocated to efforts to combat antibiotic resistance in the U.S.
How Efficiency Checklists Help Hospitals Save Energy, Water and Money
Designing with Heart: Seen Health Center Blends Cultural Warmth and Clinical Care
Rutgers Health and University Hospital Breaks Ground on Campus Expansion
What to Consider When Modernizing Healthcare Facilities
Corewell Health Beaumont Troy Hospital to Build New Tower